語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Safety of Biologics Therapy = Monocl...
~
SpringerLink (Online service)
Safety of Biologics Therapy = Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Safety of Biologics Therapy/ by Brian A. Baldo.
其他題名:
Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins /
作者:
Baldo, Brian A.
面頁冊數:
XXI, 610 p. 106 illus., 89 illus. in color.online resource. :
Contained By:
Springer Nature eBook
標題:
Cardiology. -
電子資源:
https://doi.org/10.1007/978-3-319-30472-4
ISBN:
9783319304724
Safety of Biologics Therapy = Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins /
Baldo, Brian A.
Safety of Biologics Therapy
Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins /[electronic resource] :by Brian A. Baldo. - 1st ed. 2016. - XXI, 610 p. 106 illus., 89 illus. in color.online resource.
This long overdue title provides a comprehensive, up-to-date, state-of-the art review of approved biologic therapies, with coverage of mechanisms of action, Indications for therapy, immunogenicity and a detailed examination of adverse effects and safety of the many and diverse therapeutic agents presented in a total of 13 chapters. It is predicted that by 2016, biologics will make up half of the world's 20 top-selling drugs and by 2018, biologic medicine sales will account for almost half of the world's 100 biggest selling drugs. Recombinant proteins dominate the growing list of the more than 200 approved biotherapeutic agents with targeted antibodies, fusion proteins and receptors; cytokines; hormones; enzymes; proteins involved in blood-clotting, homeostasis and thrombosis; vaccines; botulinum neurotoxins; and, more recently, biosimilar preparations, comprising the majority of approved biologics. Written with clinicians, other health care professionals, and researchers in mind, Safety of Biologics Therapy examines, in a single volume, the full range of issues surrounding the safety of approved biologic therapies. A good understanding of the risks and safety issues of modern biologics therapy is increasingly being demanded of all those connected with their development, handling, prescribing, administration and subsequent patient management. In addition to being of great value to clinicians in all branches of medicine, and to nurses, pharmacists and researchers, this book will prove invaluable for students taking undergraduate and graduate courses in the above disciplines and in the biomedical sciences.
ISBN: 9783319304724
Standard No.: 10.1007/978-3-319-30472-4doiSubjects--Topical Terms:
593957
Cardiology.
LC Class. No.: RC681-688.2
Dewey Class. No.: 616.12
Safety of Biologics Therapy = Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins /
LDR
:03041nam a22003855i 4500
001
978082
003
DE-He213
005
20200704164457.0
007
cr nn 008mamaa
008
201211s2016 gw | s |||| 0|eng d
020
$a
9783319304724
$9
978-3-319-30472-4
024
7
$a
10.1007/978-3-319-30472-4
$2
doi
035
$a
978-3-319-30472-4
050
4
$a
RC681-688.2
072
7
$a
MJD
$2
bicssc
072
7
$a
MED010000
$2
bisacsh
072
7
$a
MJD
$2
thema
082
0 4
$a
616.12
$2
23
100
1
$a
Baldo, Brian A.
$4
aut
$4
http://id.loc.gov/vocabulary/relators/aut
$3
1077911
245
1 0
$a
Safety of Biologics Therapy
$h
[electronic resource] :
$b
Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins /
$c
by Brian A. Baldo.
250
$a
1st ed. 2016.
264
1
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2016.
300
$a
XXI, 610 p. 106 illus., 89 illus. in color.
$b
online resource.
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
347
$a
text file
$b
PDF
$2
rda
520
$a
This long overdue title provides a comprehensive, up-to-date, state-of-the art review of approved biologic therapies, with coverage of mechanisms of action, Indications for therapy, immunogenicity and a detailed examination of adverse effects and safety of the many and diverse therapeutic agents presented in a total of 13 chapters. It is predicted that by 2016, biologics will make up half of the world's 20 top-selling drugs and by 2018, biologic medicine sales will account for almost half of the world's 100 biggest selling drugs. Recombinant proteins dominate the growing list of the more than 200 approved biotherapeutic agents with targeted antibodies, fusion proteins and receptors; cytokines; hormones; enzymes; proteins involved in blood-clotting, homeostasis and thrombosis; vaccines; botulinum neurotoxins; and, more recently, biosimilar preparations, comprising the majority of approved biologics. Written with clinicians, other health care professionals, and researchers in mind, Safety of Biologics Therapy examines, in a single volume, the full range of issues surrounding the safety of approved biologic therapies. A good understanding of the risks and safety issues of modern biologics therapy is increasingly being demanded of all those connected with their development, handling, prescribing, administration and subsequent patient management. In addition to being of great value to clinicians in all branches of medicine, and to nurses, pharmacists and researchers, this book will prove invaluable for students taking undergraduate and graduate courses in the above disciplines and in the biomedical sciences.
650
0
$a
Cardiology.
$3
593957
650
0
$a
Endocrinology .
$3
1254221
650
0
$a
Gastroenterology .
$3
1254565
650
0
$a
Oncology .
$3
1253469
650
2 4
$a
Endocrinology.
$3
645497
650
2 4
$a
Gastroenterology.
$3
673684
650
2 4
$a
Oncology.
$3
593951
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
776
0 8
$i
Printed edition:
$z
9783319304700
776
0 8
$i
Printed edition:
$z
9783319304717
776
0 8
$i
Printed edition:
$z
9783319808192
856
4 0
$u
https://doi.org/10.1007/978-3-319-30472-4
912
$a
ZDB-2-SME
912
$a
ZDB-2-SXM
950
$a
Medicine (SpringerNature-11650)
950
$a
Medicine (R0) (SpringerNature-43714)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入